Source: Investing.com ↗

Ascendis Pharma authorizes $400 million share buyback program

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,872.83

-0.36%

ETH/USDT

$2,734.92

-0.54%

ZEC/USDT

$1,625.52

+7.95%

XRP/USDT

$1.60

+3.83%